BIOTRONIK Excellence for Life

Indicated for de novo coronary artery lesions^a

Support

Resorbable coronary scaffolds widen coronary artery stenoses and provide temporary vessel support. Thereby, scaffolds enable unobstructed blood flow in the coronary arteries with low rates of stent thrombosis (ST) and target lesion revascularization (TLR).

Resorb

By degrading after fulfilling their scaffolding function, they offer all options of future therapies.

Working alongside physicians and listening closely to their needs, we have together developed a complete Conduction System Pacing (CSP) Solution, consisting of the world's first and only approved MR Conditional CSP system¹, comprehensive training, and expert technical support.

BIOTRONIK’s CSP system is composed of three proven components: 

• Selectra 3D – a broad range of optimally designed catheters delivering excellent handling²
• Solia S – the most popular choice of stylet-driven leads for LBBAP³, providing enhanced stability²
• Amvia – the first family of pacemakers approved for LBBAP.¹

With a collaboratively developed system and practical training programs, BIOTRONIK’s CSP Solution gives you the confidence and ease to undertake left bundle branch area pacing (LBBAP) approach.

Oscar^® (One Solution: Cross. Adjust. Restore) multifunctional peripheral catheter is an innovative new all-in-one device that is intended to facilitate lesion access, crossing, and restoring blood flow. It is composed of three fully user-adjustable components:

• Oscar support catheter with integrated Lock Grip
• Oscar extendable dilator
• Oscar length-adjustable PTA balloon

The Oscar support catheter and dilator are used in tandem to enable lesion access and crossing with a compatible guidewire. Each Oscar catheter configuration contains one length adjustable PTA balloon to restore the blood flow.

BIOTRONIK’s latest insertable cardiac monitor, BIOMONITOR IV, comes with SmartECG, an intelligent system powered by artificial intelligence and advanced algorithms to provide actionable clinical insights.^1,2

• Reduces 86% of false detections across all major arrhythmias³
• Streamlines ICM monitoring with intuitive templates and reports
• The industry’s first to discriminate between PVCs and PACs^6,7

Reduce your review burden and achieve timely and accurate diagnosis to focus on what’s most important – the patient.